| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/16/2014 | WO2014010910A1 Compound, organic electronic element using same, and electronic device thereof |
| 01/16/2014 | WO2014010897A1 Compound, organic electric element using same, and electronic device thereof |
| 01/16/2014 | WO2014010824A1 Heterocyclic compound and organic electronic element containing same |
| 01/16/2014 | WO2014010823A1 Heterocyclic compound and organic electronic element containing same |
| 01/16/2014 | WO2014010748A1 Cyclopropane derivative having bace1 inhibiting activity |
| 01/16/2014 | WO2014010611A1 Organic electroluminescence element and electronic apparatus |
| 01/16/2014 | WO2014009833A2 Complement pathway modulators and uses thereof |
| 01/16/2014 | WO2014009495A1 Antiproliferative benzo [b] azepin- 2 - ones |
| 01/16/2014 | WO2014009479A1 Stilbene compounds |
| 01/16/2014 | WO2014009302A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 01/16/2014 | WO2014008992A1 Pyrimidine pyrazolyl derivatives |
| 01/16/2014 | WO2014008838A1 Bis-indolylacetic acid derivative attached with aryl substituted methyl, and preparation method and use thereof |
| 01/16/2014 | WO2012174487A8 Bromodomain inhibitors and uses thereof |
| 01/16/2014 | US20140018544 No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents |
| 01/16/2014 | US20140018541 Umsymmetrical bisazides for chemoselective sequential ligation |
| 01/16/2014 | US20140018389 Hepatitis C Virus Inhibitors |
| 01/16/2014 | US20140018376 Use of 1H-Quinazoline-2,4-Diones |
| 01/16/2014 | US20140018368 Hedgehog antagonists having zinc binding moieties |
| 01/16/2014 | US20140018363 2-aryl-4-quinazolinones and their pharmaceutical compositions |
| 01/16/2014 | US20140018318 N1- and N2-CARBAMOYL-1,2,3-TRIAZOLE SERINE HYDROLASE INHIBITORS AND METHODS |
| 01/16/2014 | US20140018313 Antiviral compounds |
| 01/16/2014 | US20140017195 Hepatitis C Virus Inhibitors |
| 01/16/2014 | CA2877445A1 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 01/16/2014 | CA2877187A1 Antiproliferative benzo [b]azepin-2-ones |
| 01/15/2014 | EP2684874A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors |
| 01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 01/15/2014 | EP2683712A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/15/2014 | EP2683711A1 New pyridazinone and pyridone compounds |
| 01/15/2014 | EP2683709A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
| 01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
| 01/15/2014 | EP2683693A1 Rorgammat inhibitors |
| 01/15/2014 | EP2683687A1 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/15/2014 | EP2683297A1 Exposure kit including a fluorescent agent and a cyanoacrylate, and method for the co-fumigation of a fluorescent agent and a cyanoacrylate |
| 01/15/2014 | CN103508957A Hydroxyethyl pyrazole compound or aminoethyl pyrazole compound, preparation method and use thereof |
| 01/15/2014 | CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/15/2014 | CN102276514B Fluorene-bridged blue phosphorescent main body material and preparation method and application thereof |
| 01/15/2014 | CN102203067B Hedgehog pathway modulators |
| 01/15/2014 | CN101723936B Kinase suppressor and pharmaceutical application thereof |
| 01/14/2014 | US8629285 Imidazole compounds that modulate HSP90 activity |
| 01/14/2014 | US8629273 Diazinylpyrazolyl compounds |
| 01/14/2014 | US8629156 Tryptophan hydroxylase inhibitors |
| 01/14/2014 | US8629132 Kinase inhibitors |
| 01/14/2014 | CA2746423C Aminopyrazole compounds as chki inhibitors |
| 01/14/2014 | CA2742248C Melanocortin receptor agonists |
| 01/09/2014 | WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors |
| 01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | WO2014007395A1 Pyrazole or thiazole derivative, salt thereof, and pest control agent |
| 01/09/2014 | WO2014006066A1 Triazole compounds as antivirals |
| 01/09/2014 | WO2014005182A1 Phosphoinositide 3-kinase (pi3k) inhibitors |
| 01/09/2014 | WO2012162254A8 Inhibitors of lrrk2 kinase activity |
| 01/09/2014 | US20140011997 Neprilysin inhibitors |
| 01/09/2014 | US20140011961 Precursor compound connected to solid support for manufacturing 18f radiopharmaceutical, method for manufacturing same, and application thereof |
| 01/09/2014 | US20140011845 Chemical compounds |
| 01/09/2014 | US20140011825 Compounds and Compositions as Protein Kinase Inhibitors |
| 01/09/2014 | US20140011816 Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
| 01/09/2014 | US20140011807 Nitrogen-containing saturated heterocyclic compound |
| 01/09/2014 | US20140011803 Phenyl amino pyrimidine compounds and uses thereof |
| 01/09/2014 | US20140011801 Heteroaryl quinazoline derivatives |
| 01/09/2014 | US20140011775 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/09/2014 | US20140010783 Antiviral compounds |
| 01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
| 01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
| 01/08/2014 | EP2682392A2 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same |
| 01/08/2014 | EP2681207A2 Heterocyclic compounds for the inhibition of pask |
| 01/08/2014 | EP2681206A1 Mst1 kinase inhibitors and methods of their use |
| 01/08/2014 | EP2681200A1 Benzimidazole inhibitors of the sodium channel |
| 01/08/2014 | EP2680852A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/08/2014 | EP2680847A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof |
| 01/08/2014 | EP2680694A1 Histone deacetylase inhibitors |
| 01/08/2014 | CN103502244A Compound for increasing kinase active and application thereof |
| 01/08/2014 | CN103502243A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/08/2014 | CN103502242A Isoindolinone derivatives |
| 01/08/2014 | CN103502241A Substituted pyrimidinyl-pyrroles active as kinase inhibitors |
| 01/08/2014 | CN103502240A Azole derivative |
| 01/08/2014 | CN103502239A Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (SKY) |
| 01/08/2014 | CN103502237A FAAH inhibitors |
| 01/08/2014 | CN103502223A Benzoimidazole derivatives for use in light - emitting devices |
| 01/08/2014 | CN103501615A Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi |
| 01/08/2014 | CN103497540A Composite pigment powder as well as preparation method and application thereof |
| 01/08/2014 | CN103497179A Pyrimidine derivatives with benzimidazole structural units as well as preparation method and application thereof |
| 01/08/2014 | CN103497178A Irbesartan and repaglinide co-amorphous substance |
| 01/08/2014 | CN103497177A Amino heterocyclic aromatic compound serving as c-Met inhibitor, and preparation method thereof |
| 01/08/2014 | CN102382102B Amide compound |
| 01/08/2014 | CN102272125B 哒嗪酮衍生物 Pyridazinone derivatives |
| 01/08/2014 | CN102015691B Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors |
| 01/08/2014 | CN101541781B Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 01/08/2014 | CN101426772B Benzotriazine inhibitors of kinases |
| 01/07/2014 | US8624037 Imidazolidine-2,4-dione derivatives and use thereof as a medicament |
| 01/07/2014 | US8624025 Antiviral agents |
| 01/07/2014 | US8623902 Microbiocides |
| 01/07/2014 | US8623899 Bis-benzimidazole derivatives as hepatitis C virus inhibitors |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623877 Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 01/07/2014 | US8623872 Quinazolinone derivatives as PARP inhibitors |
| 01/07/2014 | US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 01/07/2014 | US8623866 Nitrogen containing heteroaryl compounds |
| 01/07/2014 | US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |